A new non invasive diagnostic test for the lactose intolerance or deficiency of the lactase intestinal enzyme has been developed, based on a novel product (sugar of new synthesis).  This test has been developed to replace the objections that present the current systems of diagnose.  The method is extremely simple and consists in the ingestion of a small dose of the new sugar and the subsequent measurement in urine or blood of the by-products. 

Clinical trials carried out and in course: 

1.  Clinical trials in Phase I and Ib.  It has been carried out in healthy adult volunteers. 

2.  Clinical trial in Phase II/III. In course, in patients with suggestive clinic of intolerance to the lactose, whether grade primary or secondary. 

3.  This last trial is being carried out in the follow hospitals:

Madrid: 
- Hospital Universitario la Paz 
- Hospital Universitario Ramón y Cajal 
- Hospital Universitario 12 de Octubre 
- Hospital Universitario Príncipe de Asturias 
- Hospital Universitario Fundación Alcorcón 
- Hospital General Universitario Gregorio Marañón 
- Hospital Clínico San Carlos 

Sevilla: 
- Hospital San Juan de Dios del Aljarafe 
- Hospital Victoria Eugenia de la Cruz Roja 
- Hospital Virgen de la Macarena 
- Hospital San Agustín 

Valencia: 
- Hospital General Universitario de Valencia

Expected advantages of the system: 

- Easy and fast evaluation of the results
- High reliability
- Harmlessness
- Routine and low price equipment
-Indicative Scoreboard of the functional integrity of the intestinal mucous membrane

Return